Exscientia scoops award for Best Digital Health Solution
Published on 28 October 2022
Milton Park-based, AI drug discovery company Exscientia has won the award for Best Digital Health Solution at the Prix Galien USA 2022 Awards for its end-to-end AI-driven precision medicine platform.
The awards were hosted by The Galien Foundation, who foster the open exchange of ideas to drive scientific innovation in medicine and recognised the great potential of Exscientia’s pioneering platform.
As leaders in the field, Exscientia says that AI technology has enormous potential to revolutionise how medicinal drugs are discovered and designed to achieve better, faster outcomes for patients at accessible costs.
Congratulations to the whole team at Exscientia whose boundless intellectual curiosity has enabled this innovation and to the various partners and collaborators who contributed to the platform.
